Cycloserine-induced neuropsychiatric toxicity in multidrug-resistant tuberculosis: association with peak plasma concentration
Microbiology Spectrum · 2025
DOI: 10.1128/spectrum.01437-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, 2025. Verfasst von Junjie Cheng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Zhejiang Hospital of Integrated Traditional Chinese and Western Medicine, Hangzhou, China. Hauptthemen laut MEDLINE: Cycloserine, Tuberculosis, Multidrug-Resistant, Antitubercular Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hangzhou Agriculture and Social Development Scientific Research Project, Hangzhou Biomedicine and Health Industry Development Project, Hangzhou Pharmaceutical Association Hospital Pharmaceutical Innovation Research Funding Project.
Abstract (Originalsprache)
Cycloserine (Cs) is a crucial anti-multidrug-resistant tuberculosis medication with significant clinical efficacy. However, its clinical application is limited by neuropsychiatric-related adverse drug reactions (ADRs). This study retrospectively evaluated the peak plasma concentration ( C max ) of Cs and Cs-related neuropsychiatric ADRs and analyzed the risk factors of developing neuropsychiatric ADRs. A multivariable ordinal logistic regression model was built to predict the incidence of neuropsychiatric ADRs. This study enrolled a total of 136 participants, with a cumulative incidence of neuropsychiatric ADRs of 12.5%. Patients experiencing ADRs had significantly higher Cs C max compared to those without ADRs. The risk of ADRs rose with increasing Cs exposure, especially when C max exceeded 30 mg/L. Receiver operating characteristic analysis demonstrated the strong predictive value of C max for neuropsychiatric ADRs. Notably, the predictive efficacy of the logistic regression model significantly improved after incorporating drinking history as a covariate, achieving a final predictive accuracy of 87.6%. Cs C max serves as a critical indicator for predicting Cs-related neuropsychiatric ADRs. Dynamic monitoring of Cs C max combined with alcohol history assessment can enable accurate identification of high-risk populations for neuropsychiatric ADRs, thereby providing a scientific basis for developing individualized medication regimens and implementation of early interventions. IMPORTANCE Cycloserine (Cs) is a vital medication for treating multidrug-resistant tuberculosis (MDR-TB), but its use is often limited by severe neuropsychiatric side effects such as depression, anxiety, and seizures. This study highlights the critical role of monitoring Cs peak plasma concentration ( C max ) to predict and mitigate these adverse reactions. By analyzing data from 136 patients, the researchers found that higher Cs C max levels significantly increase the risk of neuropsychiatric toxicity, particularly when concentrations exceed 30 mg/L. Additionally, a history of alcohol consumption further elevates this risk. These findings provide a practical approach for clinicians: regular monitoring of Cs levels and assessing alcohol use can help identify high-risk patients early, enabling timely adjustments to treatment plans. This work not only enhances patient safety but also supports the broader goal of improving MDR-TB treatment outcomes by minimizing harmful side effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Zhejiang Hospital of Integrated Traditional Chinese and Western Medicine, Hangzhou, China.
- Department of Tuberculosis, Zhejiang Hospital of Integrated Traditional Chinese and Western Medicine, Hangzhou, China.
ORCID-Profile: Junjie Cheng, Jinmeng Li, Ren Zheng, Ruoying Zhang, Xinjun Cai
Förderung
- Hangzhou Agriculture and Social Development Scientific Research Project
- Hangzhou Biomedicine and Health Industry Development Project
- Hangzhou Pharmaceutical Association Hospital Pharmaceutical Innovation Research Funding Project
- Zhejiang Pharmaceutical Association Hospital Pharmacy Special Research Funding Project
- Hangzhou Health Science and Technology Project
- Zhejiang Natural Science Foundation Project
Zitieren
APA
Cheng, J., Li, J., Zheng, R., Xu, K., Ma, X., Qiu, J., Zhang, R., & Cai, X. (2025). Cycloserine-induced neuropsychiatric toxicity in multidrug-resistant tuberculosis: association with peak plasma concentration. Microbiology Spectrum. https://doi.org/10.1128/spectrum.01437-25
Vancouver
Cheng J, Li J, Zheng R, Xu K, Ma X, Qiu J, et al. Cycloserine-induced neuropsychiatric toxicity in multidrug-resistant tuberculosis: association with peak plasma concentration. Microbiology Spectrum. 2025. doi:10.1128/spectrum.01437-25
BibTeX
@article{Cheng2025,
author = {Cheng, Junjie and Li, Jinmeng and Zheng, Ren and Xu, Kan and Ma, Xiaoqing and Qiu, Junke and Zhang, Ruoying and Cai, Xinjun},
title = {Cycloserine-induced neuropsychiatric toxicity in multidrug-resistant tuberculosis: association with peak plasma concentration},
journal = {Microbiology Spectrum},
year = {2025},
doi = {10.1128/spectrum.01437-25}
}
EUVIMED